Please use this identifier to cite or link to this item:
Title: Adherence to focal spasticity guidelines: A systematic review.
Authors: Sutherland, Edwina
Hill, Bridget
Williams, Gavin
Other Authors: Ashford, S.
Berwick, S.
Fheodoroff, K.
Hoare, B.
Hastings-Ison, T.
Singer, Barbara
Keywords: Focal Muscle Spasticity
Botulinum Toxin
Functional Outcomes
Randomised Controlled Trials
Rehabilitation, Mental Health and Chronic Pain Clinical Institute, Epworth HealthCare, Victoria, Australia
Issue Date: Oct-2020
Conference Name: Epworth HealthCare Research Month 2020
Conference Location: Epworth Research Institute, Victoria, Australia
Abstract: Focal muscle spasticity is a disabling impairment, affecting as many as twothirds of people with a neurological condition. Level 1 evidence exists for the use of botulinum toxin (BoNT-A) to reduce spasticity, and this is stipulated in twenty-five international management guidelines. However, given that intramuscular BoNT-A does not always translate to improved functional outcomes, the association between other guideline-endorsed aspects of care and patient goal attainment remains unclear in the literature. Adherence to international guideline recommendations for focal spasticity management is low. Stronger guideline adherence, prioritizing recommendation importance or understanding barriers to guideline implementation could help to focus future research towards key areas of spasticity management that have the greatest impact on functional outcomes.
Type: Conference Poster
Affiliated Organisations: University of Melbourne
London North West University Healthcare NHS Trust
Schon Klinik Vogtareuth
Ludwig-Maximillians University of Munich
La Trobe University
Monash University
Edith Cowan University
Royal Childrens’ Hospital
Type of Clinical Study or Trial: Review
Appears in Collections:Research Week

Files in This Item:
File Description SizeFormat  
Sutherland, Edwina_Spasticity SR_Research Month 2020 (Lscape).pdf754.62 kBAdobe PDFThumbnail

Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.